The ascension of Sildenafil initially drove significant growth in the medicinal sector, producing a image of guaranteed gains. However, placing capital in companies heavily reliant on flagship drugs like the erectile https://ihannarxjm758225.losblogos.com/39868514/the-blue-pill-and-the-pharmaceutical-industry-a-speculative-play